Fair Value Measurement of Assets and Liabilities - Schedule of Fair Value Liabilities Measured on Recurring Basis (Detail) $ in Millions |
3 Months Ended |
|---|---|
|
Mar. 31, 2023
USD ($)
| |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
| Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] | Acquisition Integration Divestiture And Related Expenses |
| Fair Value Measurements at Reporting Date Using: Significant Unobservable Inputs (Level 3) [Member] | Fair Value, Measurements, Recurring [Member] | |
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | |
| Beginning balance December 31, 2022 | $ 17.4 |
| New contingent payments related to the Embody acquisition | 94.0 |
| Change in estimates | 0.2 |
| Settlements | (12.6) |
| Ending balance March 31, 2023 | $ 99.0 |